Last checked at 
LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
S&P CAPITAL IQ CUTS NEXT TO 'BUY' ('STRONG BUY') - TARGET 85 (91) PENCE
----------
CREDIT SUISSE RAISES BUNZL PRICE TARGET TO 1780 (1660) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES TRAVIS PERKINS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 2255 (1838) PENCE
----------
Deutsche Bank Upgrades Tesco To Buy From Hold Ups Price Target To 210p From 200p
----------
JPMORGAN RAISES HIKMA PRICE TARGET TO 2700 (2500) PENCE - OVERWEIGHT
----------
JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1390 (1370) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4500 (4400) PENCE - 'NEUTRAL'
----------
Cantor Fitzgerald Raises Royal Mail To Buy From Hold Ups Price Target To 530p From 500p
----------
BARCLAYS CUTS ABERDEEN AM TO UNDERWEIGHT (EQUAL WEIGHT) - TARGET 250 (350) PENCE
----------
SOCGEN CUTS MARKS & SPENCER PRICE TARGET TO 595 (652) PENCE - 'BUY'
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1089 (1024) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
MORGAN STANLEY CUTS SSP GROUP TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
HSBC INITIATES JLT GROUP WITH 'BUY' - TARGET 1020 PENCE
----------
JPMORGAN CUTS ROTORK PRICE TARGET TO 170 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS HALFORDS GROUP PRICE TARGET TO 380 (460) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BODYCOTE PRICE TARGET TO 510 (500) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS BTG TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 780 (900) PENCE
----------
GOLDMAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
BARCLAYS RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 428 (419) PENCE - UNDERWEIGHT
----------
BARCLAYS RAISES HISCOX PRICE TARGET TO 684 (645) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS WEIR GROUP PRICE TARGET TO 1500 (1550) PENCE - 'BUY'
----------
GOLDMAN CUTS SPECTRIS PRICE TARGET TO 2130 (2200) PENCE - 'BUY'
----------
Deutsche Upgrades Morrisons To Hold From Sell, Price Target 155p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 870 (950) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 685 (700) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SPIRE HEALTHCARE PRICE TARGET TO 395 (310) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES CAMBIAN PRICE TARGET TO 278 (222) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ABCAM PRICE TARGET TO 606 (558) PENCE - 'NEUTRAL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
19 Feb 2024 08:03
AstraZeneca's Tagrisso gains FDA approval
(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.
Read more